While independent main effects of APOE4 and FH were observed on Aβ deposition, there were no differences in cerebral glucose metabolism between the FH groups or the APOE4 groups in the brain regions typically affected in clinical AD patients in the current sample of cognitively normal elderly whose degree of degeneration is not yet progressed enough to be detected. This evidence concerns the gene APOE and Alzheimer disease.